Member Submitted Links
| This page display hyperlinks to locations that our members have uploaded. The items are by no means endorsed by this website. |
Users Online
We have 22 guests and 0 members online
No users online.
No users online.
Recent Forum Topics
- 08/24/2010 01:36 Live Cell Therapy at Advanced Medical Group (Wilsons)
- 08/21/2010 03:03 "favorite quotes or sayings" cancer related or not (olivia751)
- 08/08/2010 23:41 blood tests? (jvanderwood)
- 08/08/2010 16:12 blood tests? (charra)
- 08/03/2010 02:33 Live Cell Therapy at Advanced Medical Group (Janiels)
- 07/30/2010 16:20 What is wrong with me possibly? (Rick)
- 07/30/2010 16:13 What is wrong with me possibly? (Rick)
- 07/29/2010 17:23 Hi from Waitakere, NZ (daughter)
- 07/29/2010 15:24 older mom with MM diagnosis, now what (bandm hx)
- 07/29/2010 09:28 Hi from Waitakere, NZ (Supersid)
- 07/28/2010 09:44 Stem Cell Treatment Ukraine - EmCell Clinic (sunshine)
- 07/28/2010 09:40 Effects of Tumeric and Multiple Myeloma (sunshine)
- 07/28/2010 09:36 Motorcycle season (sunshine)
- 07/28/2010 09:34 Hi from B.C. (sunshine)
- 07/28/2010 09:27 Hi from Waitakere, NZ (sunshine)
Tag Cloud
cancer
foundation
research
multiple
website
acorn
study
patients
drug
hope
marrow
york
health
blood
jewelry
news
funding
combination
online
help
athletes
forums
medical
disease
source
cells
efforts
mmrf
hatter
plasma
program
treatments
cell
wwwfacebookcom
added
myeloma
announced
initiative
december
phase
results
medworm
search
clinical
stem
response
called
genomics
researchers
cure
given
diagnosed
event
postedphpid7304307941share
honor
time
publishers
2009
read
birthday
collection
bone
year
bring
oncology
institute
make
support
national
generation
treatment
data
today
http
proceeds
donation
items
query
velcade
article
Search Articles
Polls
Polls
Myeloma News
- International study to improve treatments for Duchenne muscular dystrophy launched
- ImmunoCellular Therapeutics Issues Letter to Shareholders
- Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID
- Cardiogenesis Corporation releases comment on STAR-heart study
- Celgene Officially Notified of ANDA Filing for REVLIMID®
Medworm
- Summer office hours have been extended. The office and hotline will close at 2:00 PM...
- With the help of IMFer Cathy Goetz' testimony, the oral-parity bill has passed in California.
- Jack Aiello named IMF Advocate of the Month!!
- BEAT CANCER TO THE FINISH LINE!Thank you to all IMFers who voted for our entry,...
- BEAT CANCER TO THE FINISH LINE!Thank you to all IMFers who voted for our entry...
- BEAT CANCER TO THE FINISH LINE!We have only a few more days left. Take 30...
- Audio of the Living Well with Myeloma Teleconference on Nutrition is on the web.
- BEAT CANCER TO THE FINISH LINE!Calling all IMFers to raise awareness by casting a vote...
Myeloma Beacon
- Pat’s Place: A Patient’s Reflections On The Progress Of Multiple Myeloma Research
- Guide To Nutrition In Multiple Myeloma – Part 2: Supplements
- Oral Busulfan Treatment May Be More Effective But Not As Safe As Melphalan Prior To...
- NICE Recommends Thalidomide Over Velcade As First Line Treatment For Multiple Myeloma In The U.K.
- Guide To Nutrition In Multiple Myeloma – Part 1: An Introduction
- Pat’s Place: Suggestions To Help Improve A Multiple Myeloma Patient’s Quality Of Life
- Velcade-Dexamethasone Therapy Improves Prognosis Of Multiple Myeloma Patients With The Chromosomal Abnormality t(4;14)
- Personal Perspective: Tips For How Every Myeloma Patient Can Be Their Own Advocate
- Etoposide Is Highly Effective For Stem Cell Mobilization In Multiple Myeloma Patients
- Hycamtin-Cyclophosphamide-Melphalan May Be Effective And Safe For Multiple Myeloma Patients
Archives by month
Visitors Counter







![]() | Today | 634 |
![]() | Yesterday | 1019 |
![]() | This week | 5448 |
![]() | Last week | 6230 |
![]() | This month | 2600 |
![]() | Last Month | 28725 |
![]() | All | 234680 |
Online (20 minutes ago): 21
Your IP: 38.107.191.84
,
Now is: 2010-09-03 15:12
Your IP: 38.107.191.84
,
Now is: 2010-09-03 15:12








